ArticleSynthetic and systems biotechnology2027
Key molecular networks underlying retinol's biphasic effects on cell proliferation through multi-omics integrative analysis using genome-scale metabolic modeling.
Article in Synthetic and systems biotechnology, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinol is widely used in skin anti-aging, yet its effects exhibit significant concentration dependence. However, the underlying biphasic mechanism, that is low concentrations promote cell proliferation while high concentrations are inhibitory, remains incompletely understood. Here, we employed multi-omics analysis and genome-scale metabolic models (GEMs) to systematically infer the key molecular networks underlying the distinct effects of retinol concentrations on human foreskin fibroblasts (HFFs). Our results suggest that low retinol concentrations appear to promote proliferation by activating the canonical retinoic acid signaling pathway and inducing sophisticated metabolic reprogramming. This reprogramming appears to involve prioritizing the coenzyme NADPH for retinol processing and antioxidant defense, which is associated with a compensatory suppression of NADPH-consuming cholesterol biosynthesis. This metabolic shift may foster a favorable intracellular environment for growth. Conversely, high concentrations are linked to a multi-system injury cascade. The observed key feature likely involves significant oxidative stress, associated with the buildup of toxic metabolic intermediates and a pro-inflammatory lipid storm marked by elevated leukotrienes. These stress responses align with the signatures of ferroptosis, a form of programmed cell death characterized by glutathione (GSH) defense system collapse and downregulation of the key regulator
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.